Watch Ticker

AC Immune SA

Go to AC Immune SA Website

$2.25

-0.20 (-8.13%)

Live

Previous Close

$2.45

Day Range

$2.19 - $2.4

Previous Day Range

$2.1552 - $2.5

Market Cap

$220.8 million USD

Day Vol.

58192

Previous Day Vol.

266013

Currency

USD

Primary Exchange

Nasdaq

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Ac Immune Sa - AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

AC Immune reported Q2 2025 financial results, highlighting progress in neurodegenerative disease therapies with three active immunotherapies in Phase 2 clinical development and a cash balance of CHF 127.1 million providing funding into Q1 2027.

Related tickers: ACIU.

Read Full Article

Ac Immune Sa - AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update

AC Immune reported positive interim results from its Phase 2 trial of ACI-7104.056, an anti-alpha-synuclein active immunotherapy for Parkinson's disease. The company also highlighted progress in its early-stage pipeline and provided financial updates.

Related tickers: ACIU.

Read Full Article

Trending Tickers

Please sign in to view